Section of General Internal Medicine, Veterans Affairs Boston Health Care System, Boston, Massachusetts, USA.
Department of Psychosocial Oncology and Palliative Care, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
J Am Geriatr Soc. 2024 Jul;72(7):2060-2069. doi: 10.1111/jgs.18936. Epub 2024 May 22.
Hospice care leads to improved patient and family outcomes. Hospice use among older adults with end-stage kidney disease (ESKD) is markedly lower than among older adults with other serious illnesses, and the majority of those with ESKD who use hospice enroll in the last days of life. Here, our aim was to explore barriers to timely receipt of high-quality hospice care for older adults with ESKD.
Utilizing a qualitative study design, we conducted a secondary analysis focused on hospice, a theme that we identified in our larger overarching study that involved semi-structured interviews with 20 nephrologists in the United States focused on treatment decision-making in older adults with advanced chronic kidney disease. We analyzed the interview transcripts using emergent thematic analysis to develop an understanding of barriers to high-quality hospice.
With a couple notable exceptions, nephrologists voiced general support for the concept of hospice, but few recalled patients of theirs who had received hospice. Nephrologists' interviews revealed two interrelated contributors to the lack of timely access to high-quality hospice care for seriously ill older adults with ESKD: (1) nephrologists view dialysis and hospice as mutually exclusive models of care; (2) nephrologists feel unsure who should manage hospice care for patients with ESKD. The first contributor was rooted in nephrologists' narrow vision of when to consider hospice (informed, in part, by policy barriers) and, in a couple of cases, strong discomfort with hospice. The second stemmed from nephrologists' belief that neither they nor hospice are adequately prepared to provide hospice care for ESKD.
Our findings suggest that, in addition to Medicare policy change, nephrologists need to receive more training in primary palliative care skills including in indications for hospice, initiating conversations about hospice with patients, and collaborating with hospice clinicians to care for these vulnerable patients.
临终关怀可改善患者及其家属的结局。终末期肾病(ESKD)老年患者的临终关怀使用率明显低于其他患有严重疾病的老年患者,而大多数使用临终关怀的 ESKD 患者都是在生命的最后几天才登记的。在这里,我们的目的是探讨 ESKD 老年患者及时获得高质量临终关怀的障碍。
利用定性研究设计,我们对临终关怀进行了二次分析,这是我们在更大的总体研究中确定的一个主题,该研究涉及对美国 20 名肾病学家的半结构化访谈,重点是针对晚期慢性肾脏病老年患者的治疗决策。我们使用新兴的主题分析方法分析访谈记录,以了解高质量临终关怀的障碍。
除了一些值得注意的例外,肾病学家普遍支持临终关怀的概念,但很少有人记得他们的患者接受过临终关怀。肾病学家的访谈揭示了导致 ESKD 重病老年患者无法及时获得高质量临终关怀的两个相互关联的因素:(1)肾病学家将透析和临终关怀视为相互排斥的护理模式;(2)肾病学家不确定谁应该为 ESKD 患者管理临终关怀。第一个因素源于肾病学家对何时考虑临终关怀的狭隘看法(部分受政策障碍的影响),在少数情况下,对临终关怀的强烈不适。第二个因素源于肾病学家认为他们自己和临终关怀机构都没有充分准备好为 ESKD 患者提供临终关怀。
我们的研究结果表明,除了医疗保险政策的改变外,肾病学家还需要接受更多关于主要姑息治疗技能的培训,包括临终关怀的指征、与患者开始临终关怀的对话,以及与临终关怀临床医生合作,共同照顾这些脆弱的患者。